Katherine Radovanovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katherine Radovanovic has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Angela Chen
Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, USA
2 shared publications - Ferran Barrachina
Massachusetts General Hospital and Harvard Medical School Program in Membrane Biology, Nephrology Division, Department of Medicine Boston, MA 02129
2 shared publications - Isinsu Bastepe
Massachusetts General Hospital and Harvard Medical School Program in Membrane Biology, Nephrology Division, Department of Medicine Boston, MA 02129
2 shared publications - Maia Lina Elizagaray
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, and Alvin J. Siteman Cancer Center. St Louis, MO, USA
2 shared publications - Maria Agustina Battistone
Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston 02129, MA, United States
2 shared publications - Maria Carolina Avenatti
Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, USA
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Elsevier in Journal of Autoimmunity
- Vol. 164
Intercalated cells contribute to the immune responses in renal autoimmune disease
- 16 September 2026
- Published by Elsevier in Journal of Autoimmunity
- Vol. 164
Open AccessIntercalated cells contribute to the immune responses in renal autoimmune disease
- Top Cited PapersOpen Access
- 23 January 2026
- Published by Wiley in Immunological Reviews
- Vol. 338 (1) , e70107
The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
There are sex differences with immune responses where females exhibit stronger immune responses compared to males. Both sex hormones and sex chromosome differences between males and females contribute to the observed sex differences with innate and adaptive immune cell composition and function. Here, we present recent findings investigating sex differences with immune cells and responses, highlighting contributions from sex hormones or X‐linked genes. We also review the epigenetic gene regulatory mechanisms that form the inactive X chromosome (Xi), known as X‐Chromosome Inactivation (XCI), the heterochromatic nature of the Xi that allows for selective gene reactivation, and recent work investigating the mechanisms of XCI maintenance in female immune cells. We also highlight some dosage‐sensitive X‐linked genes involved in female‐biased autoimmune disease, discuss sex differences with immune signaling pathways, and sex differences with viral infections and vaccine responses with the ultimate goal to leverage these insights for the development of sex‐specific therapeutic interventions for immune‐related diseases.
- 23 January 2026
- Published by Wiley in Immunological Reviews
- Vol. 338 (1) , e70107
Top Cited PapersOpen AccessThe X Factor in Immunity: Sex Differences Shaped by the X Chromosome
There are sex differences with immune responses where females exhibit stronger immune responses compared to males. Both sex hormones and sex chromosome differences between males and females contribute to the observed sex differences with innate and adaptive immune cell composition and function. Here, we present recent findings investigating sex differences with immune cells and responses, highlighting contributions from sex hormones or X‐linked genes. We also review the epigenetic gene regulatory mechanisms that form the inactive X chromosome (Xi), known as X‐Chromosome Inactivation (XCI), the heterochromatic nature of the Xi that allows for selective gene reactivation, and recent work investigating the mechanisms of XCI maintenance in female immune cells. We also highlight some dosage‐sensitive X‐linked genes involved in female‐biased autoimmune disease, discuss sex differences with immune signaling pathways, and sex differences with viral infections and vaccine responses with the ultimate goal to leverage these insights for the development of sex‐specific therapeutic interventions for immune‐related diseases.
- Open Access
Immunomodulatory Functions of Intercalated Cells in Kidney Autoimmunity
Various autoimmune diseases frequently cause both acute and chronic kidney injuries through complex mechanisms involving autoantibodies and cellular immune responses that result in tissue damage. Intercalated cells (ICs), specialized renal tubular epithelial cells responsible for proton secretion, are strategically positioned at the epithelial-immune interface, making them ideal sensors of stress signals and potential triggers of immune responses. This study investigates the molecular mechanisms by which ICs interact with immune cells to maintain renal immune homeostasis and contribute to the development of autoimmune kidney disease. We depleted Foxp3⁺ regulatory T cells (Tregs) by injecting diphtheria toxin (DT) into male and female Foxp3-DTR mice. Two weeks after depletion, we observed autoimmune inflammation marked by increased renal immune infiltration, including neutrophils, macrophages, and subsets of T and B cells, along with the formation of ectopic lymphoid-like structures and enhanced antigen presentation. We found higher levels of renal autoantibodies in urine and serum, with antibodies depositing in glomeruli and tubules. Our analysis identified several renal antigens targeted by autoantibodies, suggesting their potential role in antibody-mediated renal injury. Kidney damage included smaller glomeruli, proximal tubular injury, an increased urine albumin/creatinine ratio, and decreased urine output. Disruption of immune tolerance led to the upregulation of inflammasome-related genes and IL-33 in ICs, which acts as a key alarmin signaling damage and promoting activation and expansion of Tregs. Our findings uncover a novel IC-Treg interaction mediated by the IL-33 pathway, revealing immune-regulating mechanisms that support renal immune tolerance. Although Tregs were initially depleted, a significant rebound in their numbers and function occurred. Understanding the cellular and molecular mechanisms behind autoimmune renal injury is crucial for developing targeted therapies and identifying appropriate biomarkers.
Open AccessImmunomodulatory Functions of Intercalated Cells in Kidney Autoimmunity
Various autoimmune diseases frequently cause both acute and chronic kidney injuries through complex mechanisms involving autoantibodies and cellular immune responses that result in tissue damage. Intercalated cells (ICs), specialized renal tubular epithelial cells responsible for proton secretion, are strategically positioned at the epithelial-immune interface, making them ideal sensors of stress signals and potential triggers of immune responses. This study investigates the molecular mechanisms by which ICs interact with immune cells to maintain renal immune homeostasis and contribute to the development of autoimmune kidney disease. We depleted Foxp3⁺ regulatory T cells (Tregs) by injecting diphtheria toxin (DT) into male and female Foxp3-DTR mice. Two weeks after depletion, we observed autoimmune inflammation marked by increased renal immune infiltration, including neutrophils, macrophages, and subsets of T and B cells, along with the formation of ectopic lymphoid-like structures and enhanced antigen presentation. We found higher levels of renal autoantibodies in urine and serum, with antibodies depositing in glomeruli and tubules. Our analysis identified several renal antigens targeted by autoantibodies, suggesting their potential role in antibody-mediated renal injury. Kidney damage included smaller glomeruli, proximal tubular injury, an increased urine albumin/creatinine ratio, and decreased urine output. Disruption of immune tolerance led to the upregulation of inflammasome-related genes and IL-33 in ICs, which acts as a key alarmin signaling damage and promoting activation and expansion of Tregs. Our findings uncover a novel IC-Treg interaction mediated by the IL-33 pathway, revealing immune-regulating mechanisms that support renal immune tolerance. Although Tregs were initially depleted, a significant rebound in their numbers and function occurred. Understanding the cellular and molecular mechanisms behind autoimmune renal injury is crucial for developing targeted therapies and identifying appropriate biomarkers.